Clin Med Insights Endocrinol Diabetes 15:11795514221086634
If pancreatitis is suspected, Wegovy should be discontinued and appropriate diagnostic tests performed urgently Gallbladder problems : Rapid weight loss increases risk of gallstone formation, with cholelithiasis reported in approximately 1.6% of Wegovy users Intestinal obstruction/ileus : Cases have been reported in post-marketing surveillance, particularly in patients with pre-existing GI conditions Management strategies recommended by healthcare professionals include: Eating smaller, more frequent meals rather than large portions Avoiding high-fat, spicy, or heavily processed foods Staying well-hydrated, particularly if experiencing diarrhoea or vomiting, to prevent dehydration and potential acute kidney injury Not lying down immediately after eating to minimise reflux Ensuring adequate fibre intake to prevent constipation Taking the medication on the same day each week to maintain steady levels Most GI side effects improve over time as the body adjusts to the medication, typically becoming less troublesome after 4-8 weeks at each dose level
Researchers use Lipo C to investigate fat utilization, liver detoxification, and metabolic signaling pathways involved in lipid breakdown and energy regulation
Understanding an individual's unique toolbox for oxidative stress can provide invaluable insights into their predisposition to age-related diseases and their overall aging trajectory
Your appeal should directly respond to why coverage was denied
